I think we have to be concerned that we've seen this significant decline in pharmaceutical spending in Canada over the past.... I took that off the ISED website and corrected for inflation and growth in the population, and we've had a significant reduction in per capita spending.
Many of the pharmaceutical companies are really concerned about two regulatory issues, one being intellectual property and their protection of patents. I happen to know that a very large company was going to invest in Canada recently and decided not to because of that.
The price control issue is also a very significant thing. If we talk about having vaccine manufacturing capability and other things, I think it's going to be very important to make sure we are attractive for pharmaceutical company investments. We have to be careful, then, with the way we frame our policies.